Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Ansiolíticos, Ansiedad, Pregabalina, Trastornos del comportamiento social, Aumento de peso - efectos de medicamentos.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder / Atul C. Pande en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 2 (Abril)
[artículo]
Título : Efficacy of the novel anxiolytic pregabalin in social anxiety disorder : A placebo-controlled, multicenter study Tipo de documento: texto impreso Autores: Atul C. Pande, Autor ; Douglas E. Feltner, Autor ; James W. Jefferson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 141-149 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Ansiedad, Pregabalina, Trastornos del comportamiento social, Aumento de peso - efectos de medicamentos. Resumen: Pregabalin is a novel compound in the development for the treatment of anxiety disorders. The safety and efficacy of pregabalin for the treatment of social anxiety disorder was evaluated in a double-blind, multicenter clinical trial in which 135 patients were randomized to 10 weeks of double-blind treatment with either pregabalin 150 mg/d, pregabalin 600 mg/d, or placebo. Link: ./index.php?lvl=notice_display&id=30962
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 2 (Abril) . - pp. 141-149[artículo] Efficacy of the novel anxiolytic pregabalin in social anxiety disorder : A placebo-controlled, multicenter study [texto impreso] / Atul C. Pande, Autor ; Douglas E. Feltner, Autor ; James W. Jefferson, Autor . - 2023 . - pp. 141-149.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 2 (Abril) . - pp. 141-149
Palabras clave: Ansiolíticos, Ansiedad, Pregabalina, Trastornos del comportamiento social, Aumento de peso - efectos de medicamentos. Resumen: Pregabalin is a novel compound in the development for the treatment of anxiety disorders. The safety and efficacy of pregabalin for the treatment of social anxiety disorder was evaluated in a double-blind, multicenter clinical trial in which 135 patients were randomized to 10 weeks of double-blind treatment with either pregabalin 150 mg/d, pregabalin 600 mg/d, or placebo. Link: ./index.php?lvl=notice_display&id=30962